Cargando…
Immunomodulatory role of metalloproteinase ADAM17 in tumor development
ADAM17 is a member of the a disintegrin and metalloproteinase (ADAM) family of transmembrane proteases involved in the shedding of some cell membrane proteins and regulating various signaling pathways. More than 90 substrates are regulated by ADAM17, some of which are closely relevant to tumor forma...
Autores principales: | Wang, Kai, Xuan, Zixue, Liu, Xiaoyan, Zheng, Meiling, Yang, Chao, Wang, Haiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715963/ https://www.ncbi.nlm.nih.gov/pubmed/36466812 http://dx.doi.org/10.3389/fimmu.2022.1059376 |
Ejemplares similares
-
Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response
por: Wang, Kai, et al.
Publicado: (2022) -
ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice
por: Almishri, Wagdi, et al.
Publicado: (2022) -
The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer
por: He, Luying, et al.
Publicado: (2023) -
Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
por: Wang, Qi, et al.
Publicado: (2022) -
Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris
por: Kugelmann, Daniela, et al.
Publicado: (2022)